Three unapproved substances in a supplement sold for three and a half years — 22 records of the kind (Modern Warrior Life)
The U.S. FDA classified "Modern Warrior Ready" (60 capsules) from Modern Warrior Life, LLC as Class I — its most serious category — after FDA analysis revealed unapproved ingredients including tianeptine, 1,4-DMAA, and aniracetam. The product had been distributed nationwide from April 2022 until December 8, 2025.
Recall overview (primary data)
- ClassificationClass I (most serious)
- Product typeFood
- Recalling firmModern Warrior Life, LLC
- ReasonFDA analysis revealed the presence of unapproved ingredients including tianeptine, 1,4 DMAA, and aniracetam.
- DistributionThe recalled product was distributed to customers nationwide from April 2022 until December 8, 2025
- Recall initiated2026-01-09
Key points
- Recall number H-1178-2026; FDA Class I, the most serious category; status Ongoing.
- The product is "Modern Warrior Ready, Dietary Supplement, 60 CAPSULES."
- The reason is FDA analysis revealing unapproved ingredients: tianeptine, 1,4-DMAA, and aniracetam.
- Distributed to customers nationwide from April 2022 until December 8, 2025; quantity recorded as Unknown.
- Voluntary, firm-initiated. Initiated 2026-01-09; reported 2026-07-29.
- Of the 1,408 FDA recall records this site holds as of 2026-09-01, 22 mention an unapproved substance or an undeclared drug ingredient.
1What an unapproved ingredient means here
In the United States, dietary supplements are handled under a framework separate from drugs and are not approved for efficacy and safety before sale. Instead, the range of substances that may be included is defined, and a product containing something outside that range is unlawful whether or not it appears on the label. The three substances FDA analysis is said to have found are not permitted as supplement ingredients.
From a consumer's point of view, the product contained something no amount of label-reading would reveal.
2The three substances found
Tianeptine is used as a medicine in some countries but is not permitted as a supplement ingredient in the United States, and FDA has issued repeated warnings about it. 1,4-DMAA is a synthetic compound described as having stimulant effects; FDA does not permit its use in supplements. Aniracetam is one of the compounds known as racetams, likewise not permitted as a supplement ingredient.
Finding all three in a single product is what places this recall in Class I, the most serious category. For the health effects of each substance, consult FDA and medical professionals.
3Three and a half years, nationwide
What stands out here is the length of the distribution period. According to the record, the product was sold to customers nationwide from April 2022 until December 8, 2025, and the quantity is listed as Unknown.
Recovering a product sold over three and a half years through recall notices alone is difficult in practice, and the six months between initiation (2026-01-09) and report (2026-07-29) also reflects how hard this kind of case is to trace.
4Twenty-two records name an unapproved substance
Of the 1,408 FDA recall records this site holds as of 2026-09-01, 22 mention an unapproved substance or an undeclared drug ingredient.
The count is not large. But this type differs in kind from the rest, because it can carry the possibility that the substance was meant to be there. It is not a broken process that fixing ends, and the same seller can reappear under another product name. That this one stayed on sale for three and a half years shows how long it can take to surface.
Why it matters
Quality assurance for supplements cannot stop at microbial and foreign-object control. Verifying ingredient identity — what is actually in the product — is the central step for preventing unapproved substances from entering. For products sold over long periods, purchase-history notification largely determines whether a recall works at all, so securing customer contact routes for each sales channel in advance matters.
FAQ
What does "unapproved ingredient" mean?
What are the substances that were found?
Why does the long sales period matter?
Sources (primary)
Source: openFDA (U.S. FDA, CC0 public domain). Data is provided as-is and must not be used for medical decisions. Verify the latest and exact details with the official FDA recall information. This site is not endorsed or certified by the U.S. FDA.
- FDA recall information (official)
- openFDA (data provider)
- Recall number: H-1178-2026